Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousWhole-Body IrradiationBone and BonesImmunotherapyTissue DonorsAnemia, AplasticTransplantation ConditioningHematopoietic Stem Cell TransplantationLeukemiaLiver TransplantationTransplantation ChimeraGraft SurvivalBusulfanBone Marrow PurgingHistocompatibility TestingHistocompatibilityHematopoietic Stem CellsCyclophosphamideTransplantation, IsogeneicKidney TransplantationBone Marrow DiseasesCombined Modality TherapyMice, Inbred C57BLHematopoiesisRecurrenceRadiation ChimeraLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukemia, Myeloid, AcuteTreatment OutcomeBone Marrow ExaminationImmunosuppressive AgentsGraft RejectionRemission InductionTime FactorsHematologic NeoplasmsPrecursor Cell Lymphoblastic Leukemia-LymphomaHepatic Veno-Occlusive DiseaseBone RemodelingTransplantation ImmunologyBone Marrow NeoplasmsGraft vs Host ReactionLeukemia, MyeloidLymphocyte DepletionImmunosuppressionT-LymphocytesStem Cell TransplantationLeukocyte TransfusionLymphoma, Non-HodgkinHeart TransplantationAcute DiseaseHLA AntigensSurvival AnalysisSevere Combined ImmunodeficiencyRetrospective StudiesChimeraColony-Forming Units AssayMyelodysplastic SyndromesLung TransplantationImmunotherapy, AdoptiveLymphocyte TransfusionCyclosporineActuarial AnalysisHematologic DiseasesBone DensityAntineoplastic Combined Chemotherapy ProtocolsNuclear FamilyOrgan TransplantationLiving DonorsGraft vs Tumor EffectCarmustineCell DifferentiationMice, Inbred BALB CFollow-Up StudiesSurvival RateGraft vs Leukemia EffectPancytopeniaSpleenCytomegalovirus InfectionsLeukocyte CountCytarabineFlow CytometryGranulocyte Colony-Stimulating FactorDisease-Free SurvivalBone ResorptionMelphalanLymphomaMultiple MyelomaCells, CulturedEtoposideAntibodies, MonoclonalFatal OutcomeMice, KnockoutPrognosisAntigens, CD34Hodgkin Disease